Focus
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Focus 4:505-511, Fall 2006
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* CME: Take the course for this article:
Psychopharmacology
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Mason, B. J.
* Search for Related Content
PubMed
* Articles by Mason, B. J.

REVIEW

Acamprosate for Alcohol Dependence: An Update for the Clinician

Barbara J. Mason, Ph.D.

Correspondence: Address correspondence to: Barbara J. Mason, Ph.D., Professor and Director, Laboratory of Clinical Psychopharmacology; Co-Director, Pearson Center for Alcoholism and Addiction Research, The Scripps Research Institute, 10550 North Torrey Pines Road, TPC-5, La Jolla, CA 92037; Tel: 858-784-7324; Fax: 858-784-7340; email: mason{at}scripps.edu

Alcohol dependence is a chronic, relapsing disorder affecting more than 8 million Americans who are at increased risk for negative interpersonal and health consequences from pathological drinking. Successful treatment would potentially decrease these risks and lessen the tremendous personal and societal burdens attributed to this disorder. Psychosocial interventions without pharmacotherapy have long been the traditional treatment approach, but relapse is common. Advances in the identification of neurotransmitter systems involved in the addiction cycle have led to the development of new medications that, used in combination with counseling, further improve treatment outcome over that with counseling alone. Acamprosate is one of the medications that have shown success in promoting abstinence in alcohol-dependent individuals. For some patients, integrating acamprosate therapy into clinical practice as a complement to psychosocial interventions would enhance therapeutic options to assist in recovery. This article provides a clinically focused review of alcohol dependence as well as evidence of the safety and efficacy of acamprosate for treating this disorder.




This article has been cited by other articles:


Home page
APPI Online CMEHome page
Reference List for FOCUS Self-Assessment Examination
PsychiatryOnline CME, October 10, 2007; 2007(3): 2 - 2.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org